Kronos Bio, Inc.
Kronos Bio, Inc. (KRON) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
kron · stock forecast · 5 analysts (3M) · FMP · updated Aug 8, 2025
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$2.25
Consensus
$1.63
+85.2% upside
Low
$1.00
Median: $1.625 · Last Close: $0.88
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$1.63
85.2% upside
High Target
$2.25
155.7%
Low Target
$1
13.6%
Current Price
$0.88
as of today
Based on analyst price targets, the KRON stock price prediction for the next 12 months ranges from $1 to $2.25. The consensus KRON price forecast of $1.63 implies 85.2% upside from the current price of $0.88.
Short-Term Price Prediction
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KRON · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-08-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-12-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-12-19 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-11-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-04-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-11-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-11-10 | Goldman Sachs | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Kronos Bio, Inc. (KRON) stock. Of the recent 20 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover KRON.
Analyst Recommendation Trends
KRON analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$10M
↓ 22.1% YoY
Revenue Next Year
$2M
↓ 78.3% YoY
EPS This Year
$-1.30
EPS Next Year
$-1.30
↑ 0.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast KRON EPS of $-1.30 for the current fiscal year, based on estimates from 1 analysts. The KRON revenue forecast is $10M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The KRON stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus KRON price target is $1.63 (+85.2% upside), with an analyst consensus of Buy.
Kronos Bio, Inc. trades on NASDAQ under the ticker KRON. The KRON stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
KRON forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month KRON price target is $1.63, with a high forecast of $2.25 and a low of $1.00. The median price target is shown in the chart above when available. This implies +85.2% potential upside from the current price of $0.88.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.